Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Forrest

Showing results (1-10 of 177) with videos related to

Pageof 18
Sort By:
Advances in Experimental Medicine and Biology|August 1, 2019
Clinical Pharmacokinetics, Pharmacodynamics and Toxicodynamics of Polymyxins: Implications for Therapeutic UseRoger L Nation, Alan Forrest
Critical Care Medicine|May 23, 2006
Pharmacokinetic and pharmacodynamic research in the intensive care unit: an unmet needCurtis E Haas, Alan Forrest
Bioinformatics (Oxford, England)|August 13, 2005
SPLINDID: a semi-parametric, model-based method for obtaining transcription rates and gene regulation parameters from genomic and proteomic expression profilesKavitha Bhasi, Alan Forrest, Murali Ramanathan
Pharmaceutical Research|March 22, 2006
Application of SPLINDID, a semiparametric, model-based method for pharmacogenomic modeling of mRNA dynamicsKavitha Bhasi, Alan Forrest, Murali Ramanathan
The Primary Care Companion for CNS Disorders|February 11, 2015
High-dose olanzapine for bipolar depression: proceed with cautionVidya Perera, Alan Forrest, Junzhe Xu
Antimicrobial Agents and Chemotherapy|November 30, 2011
Vancomycin AUC24/MIC ratio in patients with complicated bacteremia and infective endocarditis due to methicillin-resistant Staphylococcus aureus and its association with attributable mortality during hospitalizationJack Brown, Kristen Brown, Alan Forrest
Clinical Therapeutics|July 25, 2016
Pharmacokinetic and Pharmacodynamic Principles of Anti-infective DosingNikolas J Onufrak, Alan Forrest, Daniel Gonzalez
Clinical Therapeutics|September 20, 2011
Outcomes and costs associated with a history of vancomycin exposure in patients with MRSA-related complicated bacteremia and infective endocarditisJack Brown, Kristen A Brown, Alan Forrest
Antimicrobial Agents and Chemotherapy|September 29, 2005
Evaluating ciprofloxacin dosing for Pseudomonas aeruginosa infection by using clinical outcome-based Monte Carlo simulationsSheryl Zelenitsky, Robert Ariano, Godfrey Harding, et al.
The Annals of Pharmacotherapy|August 19, 2003
Fluoroquinolone AUIC break points and the link to bacterial killing rates. Part 1: In vitro and animal modelsJerome J Schentag, Alison K Meagher, Alan Forrest
Pageof 18

Showing results (1-10 of 177) with videos related to

Sort By:
Pageof 18
Advances in Experimental Medicine and Biology|August 1, 2019
Clinical Pharmacokinetics, Pharmacodynamics and Toxicodynamics of Polymyxins: Implications for Therapeutic UseRoger L Nation, Alan Forrest
Critical Care Medicine|May 23, 2006
Pharmacokinetic and pharmacodynamic research in the intensive care unit: an unmet needCurtis E Haas, Alan Forrest
Bioinformatics (Oxford, England)|August 13, 2005
SPLINDID: a semi-parametric, model-based method for obtaining transcription rates and gene regulation parameters from genomic and proteomic expression profilesKavitha Bhasi, Alan Forrest, Murali Ramanathan
Pharmaceutical Research|March 22, 2006
Application of SPLINDID, a semiparametric, model-based method for pharmacogenomic modeling of mRNA dynamicsKavitha Bhasi, Alan Forrest, Murali Ramanathan
The Primary Care Companion for CNS Disorders|February 11, 2015
High-dose olanzapine for bipolar depression: proceed with cautionVidya Perera, Alan Forrest, Junzhe Xu
Antimicrobial Agents and Chemotherapy|November 30, 2011
Vancomycin AUC24/MIC ratio in patients with complicated bacteremia and infective endocarditis due to methicillin-resistant Staphylococcus aureus and its association with attributable mortality during hospitalizationJack Brown, Kristen Brown, Alan Forrest
Clinical Therapeutics|July 25, 2016
Pharmacokinetic and Pharmacodynamic Principles of Anti-infective DosingNikolas J Onufrak, Alan Forrest, Daniel Gonzalez
Clinical Therapeutics|September 20, 2011
Outcomes and costs associated with a history of vancomycin exposure in patients with MRSA-related complicated bacteremia and infective endocarditisJack Brown, Kristen A Brown, Alan Forrest
Antimicrobial Agents and Chemotherapy|September 29, 2005
Evaluating ciprofloxacin dosing for Pseudomonas aeruginosa infection by using clinical outcome-based Monte Carlo simulationsSheryl Zelenitsky, Robert Ariano, Godfrey Harding, et al.
The Annals of Pharmacotherapy|August 19, 2003
Fluoroquinolone AUIC break points and the link to bacterial killing rates. Part 1: In vitro and animal modelsJerome J Schentag, Alison K Meagher, Alan Forrest
Pageof 18